Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival

Journal of Surgical Oncology

Volumn 109, Issue 2, 2014, Pages 89-94

  Zhu, Ziman ^a   Xu, Yuefang ^a   Du, Jundong ^a   Tan, Jingwang ^a   Jiao, Huabao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

microRNA 218; overall survival; pancreatic ductal adenocarcinoma; qRT PCR; recurrence free survival

Indexed keywords

MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

MICRORNA-218; OVERALL SURVIVAL; PANCREATIC DUCTAL ADENOCARCINOMA; QRT-PCR; RECURRENCE-FREE SURVIVAL;

CARCINOMA, PANCREATIC DUCTAL; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84892927769     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23475     Document Type: Article

References (43)

1. Chen Y, Hao J, Ma W, et al.: Improvement in treatment and outcome of pancreatic ductal adenocarcinoma in north China. J Gastrointest Surg 2011; 15: 1026-1034.
2. Singh P, Srinivasan R, Wig JD:, Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment. Pancreas 2011; 40: 644-652.
3. Macgregor-Das AM, Iacobuzio-Donahue CA:, Molecular pathways in pancreatic carcinogenesis. J Surg Oncol 2013; 107: 8-14.
4. Moss EG:, MicroRNAs: Hidden in the genome. Curr Biol 2002; 12: R138-R140.
5. Bartel DP:, MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. Farazi TA, Hoell JI, Morozov P, et al.: MicroRNAs in human cancer. Adv Exp Med Biol 2013; 774: 1-20.
7. Kim GH:, MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res 2013; 161: 381-392.
8. Locke JM, Harries LW:, MicroRNA expression profiling of human islets from individuals with and without type 2 diabetes: Promises and pitfalls. Biochem Soc Trans 2012; 40: 800-803.
9. Wang W, Kwon EJ, Tsai LH:, MicroRNAs in learning, memory, and neurological diseases. Learn Mem 2012; 19: 359-368.
10. Gupta A, Swaminathan G, Martin-Garcia J, et al.: MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: New insights in pathogenesis and therapy. Viruses 2012; 4: 2485-2513.
11. Sini RA, Trink B, Nissan A:, The role of microRNA in tumorigenesis: Key players or innocent bystanders. J Surg Oncol 2009; 99: 135-136.
12. Szafranska AE, Davison TS, John J, et al.: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007; 26: 4442-4452.
13. Szafranska AE, Doleshal M, Edmunds HS, et al.: Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem 2008; 54: 1716-1724.
14. Hanoun N, Delpu Y, Suriawinata AA, et al.: The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 2010; 56: 1107-1118.
15. Zhang L, Jamaluddin MS, Weakley SM, et al.: Roles and mechanisms of microRNAs in pancreatic cancer. World J Surg 2011; 35: 1725-1731.
16. Arlt A, Müerköster SS, Schäfer H:, Targeting apoptosis pathways in pancreatic cancer. Cancer Lett 2013; 332: 346-358.
17. Liu C, Cheng H, Shi S, et al.: MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Curr Mol Med 2013; 13: 467-478.
18. Dhayat S, Mardin WA, Mees ST, et al.: Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer-A review. Int J Cancer 2011; 129: 1031-1041.
19. Oh JS, Kim JJ, Byun JY, et al.: Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 2010; 76: 5-8.
20. Gao C, Zhang Z, Liu W, et al.: Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116: 41-49.
21. Rao SA, Santosh V, Somasundaram K:, Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 2010; 23: 1404-1417.
22. Alajez NM, Lenarduzzi M, Ito E, et al.: MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011; 71: 2381-2391.
23. Davidson MR, Larsen JE, Yang IA, et al.: MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS ONE 2010; 5: e12560.
24. Tatarano S, Chiyomaru T, Kawakami K, et al.: miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol 2011; 39: 13-21.
25. He H, Di Y, Liang M, et al.: The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. Oncol Rep 2013; 30: 651-658.
26. Hurwitz M, Sawicki M, Samara G, et al.: Diagnostic and prognostic molecular markers in cancer. Am J Surg 1992; 164: 299-306.
27. Winter JM, Yeo CJ, Brody JR:, Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. Surg Oncol 2013; 107: 15-22.
28. Mardin WA, Mees ST:, MicroRNAs: Novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma ? Ann Surg Oncol 2009; 16: 3183-3189.
29. Shen J, Stass SA, Jiang F:, MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 2013; 329: 125-136.
30. Allegra A, Alonci A, Campo S, et al.: Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol 2012; 41: 1897-1912.
31. Giovannetti E, van der Velde A, Funel N, et al.: High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer. PLoS ONE 2012; 7: e49145.
32. Tavano F, di Mola FF, Piepoli A, et al.: Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas 2012; 41: 1280-1284.
33. Jamieson NB, Morran DC, Morton JP, et al.: MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res 2012; 18: 534-545.
34. Munding JB, Adai AT, Maghnouj A, et al.: Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer 2012; 131: E86-E95.
35. Preis M, Gardner TB, Gordon SR, et al.: MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer Res 2011; 17: 5812-5821.
36. Ma R, Jiang T, Kang X:, Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 2012; 31: 38.
37. Madhavan D, Cuk K, Burwinkel B, et al.: Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Front Genet 2013; 4: 116.
38. Kong X, Du Y, Wang G, et al.: Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci 2011; 56: 602-609.
39. Wang J, Chen J, Chang P, et al.: MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009; 2: 807-813.
40. Kinoshita T, Hanazawa T, Nohata N, et al.: Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 2012; 3: 1386-1400.
41. Venkataraman S, Birks DK, Balakrishnan I, et al.: MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem 2013; 288: 1918-1928.
42. He X, Dong Y, Wu CW, et al.: MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 2013; 18: 1491-1498.
43. Li CH, To KF, Tong JH, et al.: Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Gastroenterology 2013; 144: 1086-1097.